Using Nevisense to help diagnose skin cancer
Part of Cancer, Skin clinical trials.
This study tests a device called Nevisense that helps doctors check if a suspicious skin spot is a type of skin cancer called keratinocyte cancer (including basal cell carcinoma, squamous cell carcinoma, and related conditions like actinic keratosis). If you have a spot that your doctor is unsure about, this tool may help get a clearer answer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a skin spot that your doctor is unsure about and suspects could be keratinocyte skin cancer
- The spot is not on your palms, soles, scalp, beard, mustache, genitals, or inside your ears or under nails
- The spot is not on a scar, crust, psoriasis patch, or sunburn
- The spot has not been biopsied, treated with surgery, or injured before
- The spot is not on a tattoo, splinter, or other foreign object
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of marking skin before removing a non-melanoma skin cancer: using a special magnifying tool called a dermoscope versus the standard method. The goal is to see which method helps remove the cancer completely the first time.
This trial tests an artificial-intelligence smartphone app that helps spot possible skin cancer by looking at skin spots (lesions). You may benefit by getting guidance on whether your new or changing mole needs closer attention.
This trial tests a personalized aftercare report for people with low-risk skin cancer. It aims to see if this report can improve follow-up care.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
This study tests whether an artificial intelligence (AI) system can detect melanoma better by looking at 3D images of your skin. It may help find skin cancers earlier, especially if you have many moles.
This trial is testing a special light-based technique (Raman spectroscopy) to see if it can help doctors better identify skin cancers. It is for people with either basal cell or squamous cell carcinoma who are scheduled to receive brachytherapy treatment.
Hear when a new Keratinocyte Skin Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.